Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BraskemBAK +0.51%53 Debt-to-Equity is -5.43 as of Jun. 2026. GuruFocus rates BAK with a GF Score™ of 53/100 and a GF Value™ of $5.63 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 1,419 Chemicals companies, Braskem ranks worse than 70472.09% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Braskem's Debt-to-Equity or its related term are showing as below:
BAK'
s Debt-to-Equity Range Over the Past 10 Years
Min: -2587.76 Med: 5.54 Max: 786.87
Current: -5.43
During the past 13 years, the highest Debt-to-Equity Ratio of Braskem was 786.87. The lowest was -2587.76. And the median was 5.54.
BAK's Debt-to-Equity is not ranked
in the Chemicals industry.
Industry Median: 0.36
vs BAK: -5.43
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Braskem Debt-to-Equity Related Terms
Braskem Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Braskem's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Braskem's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Braskem Debt-to-Equity vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Braskem's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Braskem's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Braskem (BAK) has a Debt-to-Equity of -5.43 as of Jun. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Braskem and its competitors. According to the industry distribution chart, Braskem ranks #999999 out of 1419 companies in the Chemicals industry.
Is Braskem's Debt-to-Equity too high?
Braskem's current Debt-to-Equity is -5.43. Based on the distribution chart, Braskem ranks #999999 out of 1419 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Braskem has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Braskem's Debt-to-Equity compare to DOW?
According to the Chemicals industry distribution chart, Braskem ranks #999999 out of 1419 companies for Debt-to-Equity. This places Braskem in the lower half of its industry. The industry median Debt-to-Equity is 0.36. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Chemicals company?
The median Debt-to-Equity among Chemicals companies is 0.36, based on 1,419 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Braskem and its competitors. For the Chemicals industry, the median Debt-to-Equity is 0.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Braskem's current Debt-to-Equity is -5.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Braskem stock overvalued right now?
Based on GuruFocus' analysis, Braskem (BAK) is currently considered Possible Value Trap. The stock's GF Value™ is $5.63, compared to a current price of $1.99 — trading 64.7% below its estimated fair value. The current Debt-to-Equity is -5.43. Braskem's overall GF Score™ is 53/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Braskem (BAK), the current Debt-to-Equity is -5.43 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Braskem (BAK) Overvalued in 2026?
Based on GuruFocus' analysis, Braskem stock appears to be undervalued.
The current stock price of $1.99 is trading 64.7% below its estimated GF Value™ of $5.63.
GuruFocus considers Braskem to be Possible Value Trap.
Key valuation signals for BAK:
Debt-to-Equity: -5.43
GF Value™: $5.63 vs. price of $1.99 (64.7% below fair value)
No single metric tells the full story. See the BAK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Braskem SA is engaged in the manufacture, sale, import and export of chemicals, petrochemicals and fuels, as well as the production, supply and sale of utilities such as steam, water, compressed air and industrial gases. It also provides industrial services and is engaged in the production, supply and sale of electric energy and gas for its own use and use by other companies. Its segments include Brazil, USA and Europe; and Mexico. The Brazil segments delivered the majority of the revenue from the production and sale of chemicals; the supply of electricity and other inputs produced in these complexes to second-generation producers located in the petrochemical complexes; and the production and sale of PE, including the production of green PE made from renewable resources, and of PP.
53GF Score
Get the complete analysis for BAK
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BAK has been successfully added to your 
